Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
513 Leser
Artikel bewerten:
(2)

Global Cannabis Holdings Set To Launch Cannabis Tokens - DEA Approved MMJ International Holdings Positioned to Raise Capital

WESTERLY, RI and MONTEVIDEO, URUGUAY / ACCESSWIRE / June 28, 2023 / MMJ International Holdings (MMJ) and Global Cannabis Production (GCP) are pleased to announce their partnership to facilitate the first DEA legal import of tetrahydrocannabinol (THC) cannabis products from Uruguay to the United States. This partnership will also provide funding to develop breakthrough treatments of cannabinoid pharmaceuticals to patients.

PROVIDING SOLUTIONS

Duane Boise CEO of MMJ stated "this partnership provides the solution to one of the headwinds affecting every other cannabis company - cannabis is still considered a banned substance at the U.S. Federal level. No matter how many states or countries approve medicinal and/or recreational marijuana, doing business across state and or international borders is impossible with out the DEA registrations that MMJ has obtained."

This is where the MMJ-GCH partnership offers a competitive advantage. Specifically, the company has a schedule 1 registration with the U.S. Drug Enforcement Administration which allows for the import and export of controlled substances. Among other things, the MMJ- GCH partnership allows MMJ to fund its clinical trials, business growth, and operations by obtaining capital from GCH. Duane Boise and David Luftglass are scheduled to speak to these issues at the ORT University cannabis forum in Montevideo, Uruguay on July 11, 2023.

MMJ International Holdings, Wednesday, June 28, 2023, Press release picture

CANNABIS MEETS CRYPTO

Also on July 11, 2023 Global Cannabis Holdings (GCH) is set to launch the GCH Token, a novel crypto investment solution for the cannabis market. GCH Tokens will be issued on STOKR, a leading primary issuance platform for digital securities. STOKR, established in 2018 and supervised by Luxembourg's CSSF (financial services regulator), serves as a Virtual Assets Service Provider (VASP). Its core offering includes providing end-to-end tokenization support for financial instruments from institutional-grade investment vehicles in Luxembourg.

STOKR's advanced infrastructure and expertise have enabled GCH to issue tokenized securities on the Liquid Network, a Bitcoin side chain, offering faster transaction speeds and lower fees compared to the Bitcoin or Ethereum network.

It is important to note that only verified investors can hold and trade GCH tokens. STOKR, as a VASP, offers the necessary verification support to GCH, ensuring that GCH knows the token holders at any given time for added security and compliance. GCH Tokens are not accessible to U.S. persons due to capital market regulations, and the entire process adheres strictly to European Union Capital Market Laws.

GCH prioritizes projects such as MMJ because of the scientific and transformative impact the company will have on patients suffering from the many chronic diseases. A committee of international experts, specializing in medical and scientific cannabis, selects these projects.

David Luftglass, Managing Partner and co-founder of CGH stated that "prioritizing sustainable research and development projects is crucial for the cannabis industry to ensure a promising future for medicinal cannabis use."

Duane Boise, CEO of MMJ commented that "all of this positions MMJ and GCH "to become a leading U.S. and international player in the manufacturing of cannabis and its derivatives for FDA-approved clinical trials to produce pharmaceutical medicinal products."

MMJ and GCH recognizes that there is significant public interest in cannabis and cannabis-derived compounds. The both teams continues to work diligently with universities and scientist to fill in the knowledge gaps about the science, safety and quality of their products. We are committed to advancing our marijuana cultivation, lab formulations and clinical trials through an approach that is in line with our mission to prioritizes public health, fosters innovation, and promotes consumer confidence.

MMJ is represented by Attorney Megan Sheehan of Rhode Island.

For more information please visit www.mmjih.com. and www.globalcannabisproduction.com.

Contact: MMJ - ?Madison Hisey
?Email: media@mmjih.com?
203-231-8583

Contact: GCP? - CEO David Luftglass
?Email: David@acronyminvestment.com

SOURCE: MMJ International Holdings

View source version on accesswire.com:
https://www.accesswire.com/764204/Global-Cannabis-Holdings-Set-To-Launch-Cannabis-Tokens--DEA-Approved-MMJ-International-Holdings-Positioned-to-Raise-Capital

© 2023 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.